Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Lambda interferons in immunity and autoimmunity.
Vlachiotis S, Andreakos E. Vlachiotis S, et al. J Autoimmun. 2019 Nov;104:102319. doi: 10.1016/j.jaut.2019.102319. Epub 2019 Aug 31. J Autoimmun. 2019. PMID: 31481283 Review.
Design, structure and plasma binding of ancestral β-CoV scaffold antigens.
Hueting D, Schriever K, Sun R, Vlachiotis S, Zuo F, Du L, Persson H, Hofström C, Ohlin M, Walldén K, Buggert M, Hammarström L, Marcotte H, Pan-Hammarström Q, Andréll J, Syrén PO. Hueting D, et al. Among authors: vlachiotis s. Nat Commun. 2023 Oct 16;14(1):6527. doi: 10.1038/s41467-023-42200-x. Nat Commun. 2023. PMID: 37845250 Free PMC article.
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1.
Zuo F, Sun R, Abolhassani H, Du L, Wang Y, Vlachiotis S, Bertoglio F, Schubert M, Rezaei N, Chavoshzadeh Z, Guerra C, Cavalli A, Andréll J, Kumagai-Braesch M, Xue Y, Cao Y, Hust M, Robbiani DF, Xie XS, Hammarström L, Marcotte H, Pan-Hammarström Q. Zuo F, et al. Among authors: vlachiotis s. Lancet Reg Health West Pac. 2023 Apr;33:100762. doi: 10.1016/j.lanwpc.2023.100762. Epub 2023 Apr 12. Lancet Reg Health West Pac. 2023. PMID: 37069895 Free PMC article. No abstract available.
Immunity to SARS-CoV-2 up to 15 months after infection.
Marcotte H, Piralla A, Zuo F, Du L, Cassaniti I, Wan H, Kumagai-Braesh M, Andréll J, Percivalle E, Sammartino JC, Wang Y, Vlachiotis S, Attevall J, Bergami F, Ferrari A, Colaneri M, Vecchia M, Sambo M, Zuccaro V, Asperges E, Bruno R, Oggionni T, Meloni F, Abolhassani H, Bertoglio F, Schubert M, Calzolai L, Varani L, Hust M, Xue Y, Hammarström L, Baldanti F, Pan-Hammarström Q. Marcotte H, et al. Among authors: vlachiotis s. iScience. 2022 Feb 18;25(2):103743. doi: 10.1016/j.isci.2022.103743. Epub 2022 Jan 7. iScience. 2022. PMID: 35018336 Free PMC article.
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant.
Zuo F, Abolhassani H, Du L, Piralla A, Bertoglio F, de Campos-Mata L, Wan H, Schubert M, Cassaniti I, Wang Y, Sammartino JC, Sun R, Vlachiotis S, Bergami F, Kumagai-Braesch M, Andréll J, Zhang Z, Xue Y, Wenzel EV, Calzolai L, Varani L, Rezaei N, Chavoshzadeh Z, Baldanti F, Hust M, Hammarström L, Marcotte H, Pan-Hammarström Q. Zuo F, et al. Among authors: vlachiotis s. Nat Commun. 2022 May 13;13(1):2670. doi: 10.1038/s41467-022-30340-5. Nat Commun. 2022. PMID: 35562366 Free PMC article.